Study Reveals New Targets for Next-Generation COVID-19 Vaccines and Tests, Beyond AntibodiesAtlantic Health System
This clinical trial increased an understanding of how T cells mount a response to COVID-19 infection. These findings pave the way for diagnostic tests that detect COVID immunity based on T cells instead of antibodies. Research demonstrates that generating neutralizing antibodies rather than T cells, may not be sufficient for long-term immunity. New discoveries suggest that vaccines will need to incorporate T cell targets to generate lasting COVID-19 immunity.